Loading...
Loading...
Among the 7 tracked institutional investors we monitor, GSK (GSK PLC) is held with a combined value of $4.43B across 80,169,061 shares. The largest holder is FMR LLC with a position worth $3.73B (0.20% of their portfolio). 2 funds increased their holdings. 5 funds reduced their position.
Total Institutional Value
$4.43B
Total Shares Held
80,169,061
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $3.73B | 0.20% | +0.3% |
| 2 | STATE STREET CORP | $334.02M | 0.01% | -4.1% |
| 3 | BlackRock, Inc. | $195.97M | 0.00% | +95.7% |
| 4 | CITADEL ADVISORS LLC | $70.33M | 0.01% | -10.2% |
| 5 | Bridgewater Associates, LP | $38.56M | 0.17% | -50.7% |
| 6 | MILLENNIUM MANAGEMENT LLC | $37.19M | 0.02% | -2.8% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | $17.18M | 0.03% | -69.9% |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of GSK with a position worth $3.73B, representing 0.20% of their portfolio. In total, 7 institutional investors hold GSK with a combined value of $4.43B.
Institutional investors hold $4.43B worth of GSK stock across 7 positions. The largest institutional holder is FMR LLC with $3.73B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GSK, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GSK positions.